Both NLRP3 and GSDMD have been found playing a role in pulmonary hypertension by activating the proinflammatory cytokines and releasing cytosolic contents into the extracellular space (111, 113). This evidence concerns the gene NLRP3 and pulmonary arterial hypertension.